ANTX · AN2 Therapeutics, Inc. · Executive Compensation
$5.08
-0.14 (-2.68%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$192.75M
Shares
37.94M
Volume · Nov 20
332.71K
Avg daily vol (3M)
288.4K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $1,382,985 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $807,080 |
| Lucy Day | Chief Financial Officer | $774,336 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $1,666,117 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $1,057,350 |
| Paul Eckburg | Former Chief Medical Officer | $946,501 |
| Lucy Day | Chief Financial Officer | $812,699 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $3,342,848 |
| Lucy Day | Chief Financial Officer | $1,524,458 |
| Paul Eckburg | Former Chief Medical Officer | $1,453,786 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $1,147,944 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President and Chief Executive Officer | $3,465,533 |
| Paul Eckburg | Chief Medical Officer | $1,393,156 |
| Joshua Eizen | Chief Legal Officer | $1,354,563 |
| Lucy Day | Chief Financial Officer | $1,328,603 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Director | $1,718,989 |
| Paul Eckburg | Chief Medical Officer | $903,053 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sarah Williams | Vice President, Controller and Principal Accounting Officer | Appointed | 2026-01-29 |
| Joshua Eizen | Chief Legal Officer and Chief Operating Officer | Appointed | 2024-11-05 |
| Paul Eckburg, M.D. | Chief Medical Officer | Terminated | 2024-08-08 |
| Lucy Day | Principal Accounting Officer | Appointed | 2023-09-08 |
| Margaret (Maggie) M. FitzPatrick | Class II Director | Appointed | 2022-05-09 |
Leadership
- Eric Easom CEO, Board Member
- Lucy Day CFO, Chief Accounting Officer
- Josh Eizen COO
- Joshua Eizen COO, General Counsel
- Sarah Williams Chief Accounting Officer
- Gilbert Lynn Marks Board Member
- Joseph Zakrzewski Board Member
- Kabeer Aziz Board Member
- Margaret (Maggie) M. FitzPatrick Board Member
- Margaret FitzPatrick Board Member
- Melvin Spigelman Board Member
- Patricia Martin Board Member
- Rob Readnour Board Member
- Stephanie Wong Board Member
Key facts
CIK
1880438
CUSIP
037326105
13F (30d)
94 filings
85 filers
Visit website
Investor relations